Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-336.07M
↓ 203% below average
Average (8y)
$-110.86M
Historical baseline
Range
High:$-5.95M
Low:$-336.07M
CAGR
+65.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-336.07M | -51.7% |
| 2023 | $-221.51M | -32.7% |
| 2022 | $-166.90M | -56.3% |
| 2021 | $-106.78M | -44.3% |
| 2020 | $-74.00M | -50.1% |
| 2019 | $-49.31M | -74.6% |
| 2018 | $-28.24M | -213.8% |
| 2017 | $-9.00M | -51.2% |
| 2016 | $-5.95M | - |